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Neuroinflammation alters 
cellular proteostasis by producing 
endoplasmic reticulum stress, 
autophagy activation and 
disrupting ERAD activation
Cristina Pintado  1,3, Sandra Macías1,2, Helena Domínguez-Martín1,2, Angélica Castaño1,2 & 
Diego Ruano1,2
Proteostasis alteration and neuroinflammation are typical features of normal aging. We have previously 
shown that neuroinflammation alters cellular proteostasis through immunoproteasome induction, 
leading to a transient decrease of proteasome activity. Here, we further investigated the role of acute 
lipopolysaccharide (LPS)-induced hippocampal neuroinflammation in cellular proteostasis. In particular, 
we focused on macroautophagy (hereinafter called autophagy) and endoplasmic reticulum-associated 
protein degradation (ERAD). We demonstrate that LPS injection induced autophagy activation that 
was dependent, at least in part, on glycogen synthase kinase (GSK)-3β activity but independent of 
mammalian target of rapamycin (mTOR) inhibition. Neuroinflammation also produced endoplasmic 
reticulum (ER) stress leading to canonical unfolded protein response (UPR) activation with a rapid 
activating transcription factor (ATF) 6α attenuation that resulted in a time-dependent down-regulation 
of ERAD markers. In this regard, the time-dependent accumulation of unspliced X-box binding protein 
(XBP) 1, likely because of decreased inositol-requiring enzyme (IRE) 1α-mediated splicing activity, 
might underlie in vivo ATF6α attenuation. Importantly, lactacystin-induced activation of ERAD was 
abolished in both the acute neuroinflammation model and in aged rats. Therefore, we provide a 
cellular pathway through which neuroinflammation might sensitize cells to neurodegeneration under 
stress situations, being relevant in normal aging and other disorders where neuroinflammation is a 
characteristic feature.
Neuroinflammation and proteostasis disruption are characteristics of normal aging and some age-related 
neurodegenerative diseases. Cellular proteostasis is mainly sustained by the ubiquitin proteasome system and 
autophagy, which could act coordinately under specific situations1. A consequence of proteostasis alteration is 
ER-stress. Under this situation, cells activate the UPR, which is mediated by IRE1α, ATF6α and double-stranded 
RNA-dependent protein kinase-like endoplasmic reticulum kinase (PERK) signalling pathways2. An efficient 
UPR activation is necessary for a proper response to cellular challenges in order to resolve stress situations and 
preserve cell viability. However, others and we have demonstrated that proper UPR activation is disrupted in aged 
animals leading to neurodegeneration3–8, despite the causes of this effect are not well known.
On the other hand, low-grade chronic inflammation is also a marker for aging9–12 and represents a factor 
rising up cell vulnerability to proteasomal stress13. Importantly, neuroinflammation, autophagy and UPR are 
three interrelated processes, which can influence each other depending on different factors and stressors14, 15. In 
this regard, in vitro experiments revealed that LPS treatment induced autophagy cell death in an UPR dependent 
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manner16. However, autophagy can be also activated by other mechanisms including m-TOR inhibition or both 
GSK-3β inhibition or activation depending on the cell type or stressors. Moreover, modulation of the inflam-
matory response and cytokine production is dependent on toll-like receptor (TLR) activation of XBP1 in both 
macrophages17 and rheumatoid arthritis synoviocytes18, and also on the cross-talk between GSK-3β and XBP119. 
In consequence, a better comprehension of the in vivo relationships between neuroinflammation, UPR and 
autophagy would be useful for understanding how the neuroinflammatory response could be modulated in the 
context of aging or neurodegenerative diseases. Therefore, we set out to investigate the role of LPS-induced neu-
roinflammation on UPR and autophagy in rat hippocampus. Our results indicate that LPS injection activated 
both autophagy and UPR. Autophagy activation was depended, at least in part, on GSK-3β activity but inde-
pendent of mTOR inhibition. On the other hand, LPS injection produced a canonical but short UPR activation. 
Both ATF6α and IRE-1α were quickly attenuated, leading to down-regulation of ERAD markers. Importantly, 
the up-regulation of ERAD markers induced by proteasome inhibition was abolished in both aged rats and 
LPS-injected young animals. These results suggest that neuroinflammation-induced ERAD inactivation might 
increase cell vulnerability under proteasomal stress situations.
Results
LPS injection induces autophagy activation in rat hippocampus. We have previously demonstrated 
that LPS-induced neuroinflammation in rat hippocampus led to immunoproteasome induction and transient 
decrease of proteasome activity13. Therefore, we analyzed whether LPS injection could activate autophagy in order 
to sustain proteolytic activity. As shown, LPS injection induced a rapid and significant increase of some auto-
phagic markers such as light chain 3 (LC3)-II (Fig. 1A) and Atg7 (Fig. 1B,C and Supplementary Fig. S1A). Also, 
LPS injection triggered specific transcriptional up-regulation of the BCL2 associated athanogene 3 (bag3), but 
not bag1, which are involved in delivering proteins for degradation to the autophagy or the proteasome, respec-
tively (Supplementary Fig. S1B and C)20. Moreover, the amount of p62 protein, which is considered a marker 
for autophagic flux, showed a time-dependent decrease, but without statistical significance (Fig. 1B and D). The 
LPS-dependent increase in autophagic flux was also supported by in vitro experiments (Supplementary Fig. S1D). 
On the other hand, the master transcription factor EB (TFEB), which coordinates both autophagy and lysosomal 
biogenesis, was significantly increased after LPS injection (Fig. 1B and E) and the expression of the lysosomal 
Figure 1. LPS injection induces transient autophagy activation in rat hippocampus. (A) Representative western 
blot of LC3 I and II and graphical representation of quantification of the LC3 II/LC3 I ratio determined by 
optical density at different times after LPS injection. (B) Representative western blots of Atg7, TFEB and p62 at 
different times after LPS injection. (C–E) Graphical representation of data from optical density quantification of 
western blots corresponding to Atg7, TFEB and p62, respectively. (F) Representative western blot and graphical 
representation of quantification by optical density of lysosomal protease cathepsin D at different times after LPS 
injection. The asterisk indicates a non-specific band. Data are presented as mean ± SD (n = 4) of percentage of 
variation relative to controls. *p < 0.05, significant differences compared with control (saline-injected) animals.
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marker cathepsin D decreased significantly from 6 to 14 hours, supporting lysosomal degradation of autophago-
somes (Fig. 1F). Taken together, these data indicate that LPS injection activates autophagy in rat hippocampus. 
Importantly, the timeframe of autophagy activation was coincident with the replacement of constitutive proteas-
omes by the immunoproteasomes (Supplementary Fig. S2).
LPS-induced autophagy is partially dependent on GSK-3β activity but independent on mTOR 
inhibition. Next, we searched for the cellular pathways that might be involved in LPS-induced autophagy 
activation. Based on previous data we first focused on the Akt/GSK-3β/βcatenin axis1, 21. As shown, LPS injection 
induced early Akt activation as indicated the higher amount of both phosphoSer473Akt (Fig. 2A upper panel and 
2B) and phosphoThr308Akt (data not shown) from 3 to 6 hours. Despite Akt activation, the amount of phosphoS-
er9-GSK-3β, a target protein of Akt, was significantly reduced during this time, supporting that LPS injection 
increased basal activity of GSK-3β (Fig. 2A middle panel and 2C). This was confirmed by the significant decrease 
of β-catenin (Fig. 2A lower panel). We next tested whether GSK-3β activity could be involved in LPS-induced 
autophagy activation. For that purpose, we performed a new set of experiments using LPS-treated N13 cells in the 
presence of the GSK-3β inhibitor VII. Similarly as observed in vivo, LPS treatment increased the LC3-II/LC3-I 
ratio. However, it was partially reversed in the presence of the GSK-3β inhibitor VII (Supplementary Fig. S3). 
These data indicate that LPS-induced autophagy activation is partially dependent on GSK-3β activity.
Because mTOR inhibition is involved in autophagy activation22, we also investigated the Akt/mTOR/S6K 
pathway. As shown in Fig. 2D and E, phosphorylated mTOR at Ser2448 was significantly increased from 3 to 
6 hours but decreased at 14 and 24 hours, indicating that mTOR was activated from 3 to 6 hours. This was cor-
roborated by increased phosphorylation of the target proteint of mTOR p70 ribosomal S6 kinase (Fig. 2D lower 
panel). Taken together, these results show the LPS injection activates both Akt/GSK-3β/βcatenin and Akt/mTOR/
S6K pathways, being autophagy activation partially dependent on GSK-3β activity but independent on mTOR 
inhibition.
LPS injection induces UPR activation. We next wondered if LPS-induced proteostasis alteration could 
affect the ER homeostasis. Thus, we searched for ER-stress by evaluating UPR activation. To address this issue, we 
carried out a detailed molecular analysis of specific markers of the three arms of the UPR.
IRE1α pathway. As shown in Fig. 3A, LPS injection produced mRNA up-regulation of the Xbp1 gene 
and the phosphorylation of IRE1α (Fig. 3B), indicating that the IRE1α pathway was early activated after LPS 
Figure 2. LPS injection activates both Akt/GSK-3β/β-catenin and Akt/mTOR pathways in rat hippocampus. 
(A) Representative western blots of phopho-Ser473-Akt and Akt (upper panel), phospho-Ser9-GSK-3β and 
GSK-3β (middle panel) and β-catenin (lower panel). (B,C) Graphical representation of data from optical 
density quantification of western blots corresponding to phopho-Ser473-Akt/Akt and phospho-Ser9-GSK-3β/
GSK-3β ratios, respectively after LPS injection. (D) Representative western blots of phopho-Ser2448-mTOR and 
mTOR (upper panel) and phospho-S6K (lower panel). (E) Graphical representation of data from optical density 
quantification of western blots corresponding to phopho-Ser2448-mTOR/mTOR ratio following LPS injection. 
Data are presented as mean ± SD (n = 4) of percentage of variation relative to controls. *p < 0.05, significant 
differences compared with control (saline-injected) animals.
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injection. The Xbp1 mRNA is spliced by the nuclease activity of the phospho-IRE1α, leading after translation, to 
the active transcription factor XBP1 (sXBP1). In this regard, the amount of sXBP1 increased significantly in the 
nuclear fractions at 3 hours, decreasing afterwards in a time-dependent manner (Fig. 3C and D). By contrast, the 
unspliced XBP1 protein (usXBP1), which is produced by translation of the Xbp1 mRNA (not spliced), increased 
in an opposite manner (Fig. 3C). This resulted in a time-dependent switch in the sXBP1/usXBP1 protein ratio 
(Fig. 3E). Because IRE1α activation was observed for no longer than 3 hours, we further investigated whether the 
time-dependent reduction in the sXBP1 protein could be explained by a reduction in the amount of spliced Xbp1 
mRNA. In this regard, data demonstrated a time-dependent and significant decrease in the content of spliced 
Xbp1 mRNA that paralleled the sXBP1protein decrease (Fig. 3F).
On the other hand, the IRE1α arm activates the c-Jun N-terminal kinase (JNK) pathway through the forma-
tion of an IRE1α-TRAF2-ASK1 complex. As shown in Fig. 3G–H, LPS injection decreased phosphorylation of 
both JNK isoforms at 6 hours, supporting JNK inactivation. However, from 6 to 24 hours the phospho-JNK-2/
JNK-2 ratio remained low, whereas the phospho-JNK-1/JNK-1 ratio was significantly increased, suggesting that 
LPS-induced neuroinflammation might affect differentially both JNK isoforms.
ATF6α pathway. LPS injection also activated the ATF6α arm. While the full-length ATF6α (flATF6α) pro-
tein seemed not to be altered by LPS injection, its processing was activated leading to a significant increase of 
Figure 3. IRE1α pathway is activated following LPS injection. (A) mRNA expression of XBP1 analyzed by 
RT-real time PCR at different times after LPS injection. (B) Representative western blot of the phospho-IRE1α 
(P-IRE1α) and IRE1α proteins in the cytosolic fractions at different times after LPS injection. Note the short 
time expression. (C) XBP1 protein expression in the nuclear fractions after LPS injection. The band around 
50 kDa corresponds to the spliced active transcription factor (sXBP1), while the other one, around 30 kDa 
corresponds to the un-spliced (usXBP1) protein. Note the time-dependent increase of the usXBP1 protein. 
(D) Optical density analysis of western blots corresponding to the sXBP1 protein. (E) Graphical representation 
of the sXBP1/usXBP1 protein ratio. (F) mRNA expression of spliced XBP1 analyzed by RT-real time PCR. 
(G) Representative western blots of phospho-JNK2 and total JNK2 and phospho-JNK1 and total JNK1 in the 
cytosolic fractions at different times after LPS injection. Note both JNK1 and 2 inactivation at six hours after 
LPS injection. (H and I) Graphical representation of the phospho-JNK1/JNK1 and phospho-JNK2/JNK2 ratios, 
respectively determined by optical density analysis. Data are presented as mean ± SD (n = 4) of percentage of 
variation relative to controls. *p < 0.05, significant differences compared with control (saline-injected) animals.
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the processed ATF6α (pATF6α) protein in the cytosolic fractions, 3 hours after LPS injection (Fig. 4A and B), 
and later (6 hours) in the nuclear fractions (Fig. 4C). Accordingly, glucose regulated protein 78 (Grp78), which 
is mostly under the control of pATF6α23 increased from 6 to 14 hours (Fig. 4D and E). Importantly, the ATF6α 
pathway was briefly activated as revealed by the absence of pATF6α in the nuclear fractions beyond 6 hours, and 
the fact that it was almost depleted from 14 to 24 hours from the cytosolic fractions (Fig. 4A).
PERK pathway. As shown in Fig. 5A, LPS injection significantly increased the phospho-eukaryotic initiation 
factor 2α (peIF2α)/eIF2α ratio and the amount of the PERK-related transcription factor ATF4 from 6 to 24 hours 
(Fig. 5B), indicating PERK activation. However, the presence of ATF4 in the nuclear fractions was evident from 
3 to 6 hours, suggesting that LPS-induced nuclear translocation of ATF4 might occur in a PERK-independent 
manner. Indeed, transcriptional induction of the transcription factor C/EBP homologous protein (CHOP), which 
is under the control of ATF4, was significantly upregulated 3 hours after LPS injection. However, CHOP protein 
was not observed at any time (data not shown).
All in all, these data support that LPS injection alters hippocampal ER homeostasis leading to full UPR activa-
tion. Moreover, the three pathways showed different time courses of activation/deactivation being the ATF6α the 
later activated but the earliest attenuated.
LPS injection down-regulates ERAD markers expression. ERAD markers are under the control of 
both pATF6α and sXBP123. To investigate whether nuclear depletion of both pATF6α and sXBP1 could have 
functional relevance, we evaluated ERAD activation by analysing the expression of several ERAD-associated mol-
ecules involved in both recognition and retrotranslocation of misfolded and/or unfolded proteins. Interestingly, 
despite LPS injection produced UPR activation none of the ERAD markers analyzed was transcriptionally 
Figure 4. ATF6α pathway is activated following LPS injection. (A) Representative western blot of the ATF6α 
protein in the cytosolic fractions after LPS injection. Note the depletion of the processed ATF6α (pATF6α) 
but not of the full length ATF6α (flATF6α) at 14 and 24 hours. (B) Graphical representation of the pATF6α 
expression in the cytosolic fractions determined by optical density analysis. (C) Representative western blot of 
the pATF6α in the nuclear fractions. Note the short time expression. (D) Representative western blot of Grp78 
protein following LPS-injection. (E) Graphical representation of Grp78 expression in the cytosolic fractions 
determined by optical density analysis. Data are presented as mean ± SD (n = 4) of percentage of variation 
relative to controls. *p < 0.05, significant differences compared with control (saline-injected) animals.
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up-regulated. By contrast, the mRNA expression of ERAD markers tended to decrease in time-dependent man-
ner, being all of them significant at 24 hours (Fig. 6A). Importantly, protein analysis also revealed a significant 
reduction in the amount of some ERAD proteins (Fig. 6B). Taken together, these data demonstrate that LPS 
injection inactivated ERAD by down-regulating ERAD markers, likely as consequence of the nuclear depletion of 
both transcription factors pATF6α and sXBP1.
LPS injection attenuates lactacystin-induced up-regulation of ERAD markers. ERAD activ-
ity should be adapted in response to different stressors such as proteasome inhibition to restore proteostasis. 
Therefore, we tested whether LPS-induced ERAD inactivation could affect ERAD activation induced by protea-
somal stress. To address this issue we analyzed the expression of ERAD markers in rats subjected to proteasome 
inhibition alone (SAL+LT group), and in rats injected with LPS 24 hours before proteasome inhibition (LPS+LT 
group). In both groups, ERAD expression was analyzed 24 hours after LT injection. As expected, LT injection acti-
vated ERAD as revealed by the significant mRNA up-regulation of derlin1, derlin2 and valosin containing protein 
Figure 5. PERK pathway is activated following LPS injection. (A) Representative western blot of the phospho-
eIF2α (P-eIF2α) and eIF2α proteins expressed in the cytosolic fractions after LPS injection (upper panel), and 
graphical representation of the P-eIF2α/eIF2α ratio in the cytosolic fractions determined by optical density 
analysis (lower panel). (B) Representative western blot of the ATF4 expression in the cytosolic fractions 
after LPS-injection (upper panel), and graphical representation of ATF4 expression in the cytosolic fractions 
determined by optical density analysis (lower panel). (C) Representative western blot corresponding to the 
transcription factor ATF4 in the nuclear fractions of the same animals following LPS-injection. Note the 
presence of nuclear ATF4 at 3 hours, preceding cytosolic ATF4 accumulation. (D) mRNA expression of the 
pro-apoptotic factor CHOP analyzed by RT-real time PCR after LPS-injection. Note the short time expression 
of CHOP mRNA. Data are presented as mean ± SD (n = 4) of percentage of variation relative to controls. 
*p < 0.05, significant differences compared with control (saline-injected) animals.
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(vcp)/97 (Fig. 7A). However, when proteasome was inhibited 24 hours after LPS injection (LPS+LT), LT-induced 
upregulation was significantly reduced when compared with LT-injected animals (SAL+LT). Therefore, this data 
suggests that neuroinflammation could affect ERAD activation under proteasome stress. To test this possibility in 
a more physiological situation, we induced proteasome inhibition in aged rats, which develop low-grade chronic 
neuroinflammation9, 12, 24, and we analyzed ERAD markers. Importantly, basal expression of ERAD markers was 
significantly increased in aged rats, suggesting a higher basal ER-stress (Supplementary Fig. S4), and differences 
between acute versus chronic neuroinflammation. However, and contrary to young rats, lactacystin injection 
just up-regulated the mRNA expression of vcp/97 in aged animals, while the other markers remained similar to 
saline-injected rats (Fig. 7B). These differences were also evident at the protein level as revealed the significant 
increase of Derlin 1 in young, but no in aged, LT-treated rats (Fig. 7C). These findings strongly support that 
age-related neuroinflammation might be a relevant factor contributing to defective ERAD activation under pro-
teasome stress.
Discussion
Here, we provide solid evidence showing that neuroinflammation alters hippocampal proteostasis at different 
levels. Our findings demonstrate that LPS-induced neuroinflammation produced: (i) autophagy activation; (ii) 
UPR activation; (iii) ERAD down-regulation; and (iv) ERAD inactivation under proteasomal stress.
It is well established that in both aged hippocampus and neuroinflammation models, the constitutive pro-
teasomes are replaced by the immunoproteasomes9, 13, 25–27. We had previously demonstrated that LPS injec-
tion induced proteasome to immunoproteasome exchange that is accompanied by a transient reduction of 
proteasomal proteolytic activity13. Here, we show that LPS-induced neuroinflammation activated autophagy at 
the same time constitutive proteasomes were replaced by the immunoproteasomes. The expression of several 
macroautophagy-related markers such as LC3-II, Atg7, bag3 and p62 was altered by LPS injection. Moreover, 
the master transcription factor TFEB that coordinates autophagy activation and lysosomal biogenesis, increased 
Figure 6. LPS injection down-regulated ERAD markers expression. (A) mRNA expression of ERAD markers 
involved in both recognition (upper panel) and retro-translocation (lower panel) of unfolded and/or malfolded 
ER proteins analyzed by RT-real time PCR after LPS-injection. Note the significant reduction in the expression 
of all of the markers analyzed at 24 hours. (B) Representative western blot corresponding to selected ERAD 
proteins of the same animals at 14 and 24 hours after LPS-injection. Data are presented as mean ± SD (n = 4) 
of percentage of variation relative to controls. *p < 0.05, significant differences compared with control (saline-
injected) animals.
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after LPS injection, and the level of both pro-cathepsin and active cathepsin D were altered. In consequence, we 
propose that during neuroinflammation, autophagy might be acting as a compensatory mechanism in order to 
cope with the transient loss of proteolytic activity due to the proteasome to immunoproteasome exchange. These 
findings reinforce the idea that insufficient proteasomal activity, whatever the reasons, could activate autophagy, 
and support the functional cooperation between both proteolytic systems1, 28–30.
Autophagy is a catabolic process that can be activated in response to a multitude of stimuli through different 
cellular pathways22, 31, 32. In this regard, our data indicated that autophagy activation seemed to be dependent, at 
least in part, on GSK-3β activity. Interestingly, GSK-3β activity has also been shown to increase autophagic flux 
in adult hippocampal neural stem cells after insulin withdrawal33 and increased GSK-3β activity during ER-stress 
has been described in the context of neuroinflammation19. However, we cannot discard other factors, in addition 
to GSK-3β activity, that could contribute to LPS-induced autophagy activation. ER-stress markers such as Grp78 
up-regulation, sXBP1depletion, PERK/eIF2α phosphorylation or ATF4 stabilization, all of them observed in 
this study, have been shown to participate in the UPR-induced autophagy activation30, 34, 35. Taken toghether, 
all these data indicate that activation of the axis ER-stress-GSK-3β-autophagy might be relevant during neroin-
flammation. Surprisingly, we also observed activation of the Akt/mTOR/S6K pathway, a situation that could be 
compatible with autophagy inhibition36. In this case, Akt/mTOR/S6K activation would be modulating excessive 
autophagy through mTOR activation in order to limit cell death during neuroinflammation as previously sug-
gested22. In global, neuroinflammation could modulate autophagy by inducing two opposite pathways in order to 
get a precise control on autophagy activity. LPS injection also produced a full but faint UPR activation, support-
ing that neuroinflammation induces ER-stress. Importantly, ER-stress and UPR are related to the induction of 
proinflammatory cytokines. In particular, XBP1 is activated by TLR2 and TLR4 receptors in macrophages17 and 
it is involved in TNFα production and regulation of innate immune response17, 19. In consequence, LPS injection 
Figure 7. LPS injection attenuates lactacystin-induced up-regulation of ERAD markers. (A) mRNA expression 
of several ERAD markers was analyzed by RT-real time PCR 24 hours after saline (SAL), saline + lactacystin 
(LT) or LT-injection 24 hours after LPS-injection (LPS+LT). LT-injection induced a significant increase in the 
mRNA expression of the three ERAD markers, derlin1, derlin2 and vcp/97, compared to SAL animals. This 
mRNA up-regulation was abolished (derlin1 and derlin2) or attenuated (vcp/97) in animals that previously 
received LPS-injection (LPS+LT). (B) mRNA expression of ERAD genes in aged rat hippocampus 24 hours 
following LT-injection. Note that LT-injection just up-regulated mRNA expression of vcp/97 in aged animals, 
while the rest remained similar to aged saline-injected rats. (C) Representative western blot and quantification 
by optical density corresponding to the protein Derlin1 in both young and aged rat hippocampus 24 hours after 
LT-injection. Note the absence of induction in aged rats. Data are presented as mean ± SD (n = 4 young, and 
n = 3 aged rats) of percentage of variation relative to controls. *p < 0.05, significant differences compared with 
control (saline-injected) animals. #p < 0.05, significant differences compared with young LT-injected rats.
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might activate the IRE-1α-XBP1 axis through TLR4 receptor to stimulate TNFα production. In this regard, 
expression of TNFα, but not of IL-1β or iNOS, took place from 3 to 6 hours after LPS injection13. However, we 
also observed a weak and short activation of both ATF6α and IRE1α pathways. Interestingly, LPS injection gave 
rise to a time-dependent accumulation of the usXBP1 protein, which inversely correlated with both decreased 
sXBP1 and pATF6α depletion from the nuclear fractions. In particular, pATF6α was not longer detected in the 
nuclear fractions beyond 6 hours and was completely depleted from the cytosolic fractions from 14 to 24 hours, 
when usXBP1 protein levels were maximal. The cellular content of usXBP1 is tightly regulated37 and it has been 
shown to interact with both sXBP1 and pATF6α, but not with ATF438, 39, sequestering them from the nucleus and 
increasing proteasomal-dependent degradation of these complexes37. All these data strongly suggest the interest-
ing possibility that under in vivo neuroinflammation, usXBP1 might be modulating the duration and/or inten-
sity of the UPR. In fact, we did not observe activation of ERAD, but rather its inactivation by down-regulation 
of ERAD-associated molecules, nor CHOP expression17. An important issue will be to understand the reasons 
leading to usXBP1 accumulation in the setting of neuroinflammation. In this regard, we demonstrated that LPS 
injection produced both a reduction in the amount of sXbp1 mRNA, which support a lower IRE1α-mediated 
RNAase activity, and GSK-3β activation, two effects that seem to be causally related since GSK-3β activation 
inhibits the endonuclease activity of IRE-1α19. Thus, it is tempting to speculate that LPS-induced activation of 
GSK-3β might be involved, somehow, in the inhibition of IRE1α-mediated RNAase activity. However, we cannot 
discard that other factors such as S-nitrosylation might be affecting the IRE1α-mediated RNAase activity in the 
context of neuroinflammation40, 41.
Present data might be relevant in the context of normal aging for which low-grade chronic neuroinflamma-
tion is a hallmark9. In this regard, we have previously shown that proteasome inhibition in aged rat hippocampus 
produced: (i) weak activation and rapid attenuation of both IRE-1α and ATF6α; (ii) usXBP1 accumulation; (iii) 
GSK-3β activation; and (iv) neurodegeneration1, 7. Moreover, here we have demonstrated that ERAD was not 
properly activated following proteasome inhibition in aged rats. Importantly, all of these age-related alterations 
were reproduced in young LPS-injected rats, pointing out to neuroinflammation as a negative element disturbing 
cellular proteostasis and increasing neurodegeneration13.
In conclusion, a better understanding of how UPR activation is afected in the context of inflammation could 
have a crucial role in the comprehension of some diseases such as bowel diseases, neurodegenerative diseases or 
even aging and might help in developing relevant therapeutic tools for treating theses diseases or, at least, allevi-
ating their symptoms.
Methods
Animals. Young (3–4 months old) and aged (24–26 months old) male Wistar rats were provided by the animal 
care facility of the University of Seville. Animals were maintained at 22 to 24 °C and had free access to food and 
water. All experiments were approved by the ethical committee of the University of Seville and complied with 
international animal welfare guidelines.
Surgery. Young rats (n = 28) and aged rats (n = 3) were processed for surgery and drug injection exactly 
as previously described13. Different groups of animals were established. i) Young rats injected with LPS 
(Sigma-Aldrich, St Louis MO, USA). LPS was dissolved (5 mg/ml) in a solution of sterilized PBS and 1 μl was 
injected into both hippocampi. The rats were anesthetized with 400 mg/kg chloral hydrate and positioned in a 
stereotaxic apparatus (Kopf Instruments, Tujunga, CA). According to Paxinos’ atlas the coordinates were: 3.3 mm 
posterior, 1.6 mm lateral and 3.2 mm ventral to the bregma and 4.8 mm posterior, 5.5 mm lateral and 6.0 mm ven-
tral to the bregma. The injections were delivered over a period of 2 min, and after each, the needle was left in situ 
for an additional 5 min to avoid reflux along the injection track. After deep anesthesia with sodium pentobarbital 
animals were sacrificed at 3, 6, 14 and 24 hours after LPS injection and brains were quickly removed. Control 
animals were processed in a similar way but received 1 μl of sterilized PBS in both hippocampi. ii) Young rats 
injected with saline + lactacystin (LT) or LPS + lactacystin (LPS+LT). In this case, LT (Sigma-Aldrich, St Louis 
MO, USA) was dissolved (5 mg/ml) in a solution of sterilized PBS and 1 μl was injected into both hippocampi. For 
each case, saline or LPS was first administered and 24 hours later, LT was injected through the same drilled hole. 
Finally, after deep anesthesia with sodium pentobarbital animals were sacrificed 24 hours after the last injection. 
iii) Aged rats injected with LT. Aged rats were processed similarly as LPS injected rats but the coordinates were: 
6.0 mm posterior, ±4.6 mm lateral and 4.6 mm ventral to the bregma as previously shown7. After deep anesthesia 
with sodium pentobarbital, animals were sacrificed 24 hours after LT injection. For all cases both hippocampi 
were dissected, frozen in liquid N2, and stored at −80 °C until use.
Sample preparation. Hippocampi were homogenized in 700 μL of ice-cold sucrose buffer (0.25 M sucrose, 
1 mM EDTA, 10 mM Tris-HCl, pH 7.4), supplemented with a protease inhibitor cocktail (Sigma-Aldrich, St Louis 
MO, USA). Three hundred μL were separated and subsequently used for RNA isolation (see below). The remain-
ing homogenate (400 μL) was stored at −80 °C until use.
Subcellular fractionation. The nuclear and the cytosolic fractions were obtained from the 400 μL homoge-
nate by sequential centrifugation steps as previously described27. The homogenized sample was first cleaned by 
centrifugation at 500 g for 10 min, and the supernatant recentrifuged at 600 g for 10 min. Then, the supernatant 
was further centrifuged at 3000 g for 10 min and the pellet was re-suspended in 300 μL of sucrose buffer with 
protease inhibitors and centrifuged at 3000 g for 10 min. This step was repeated twice. The final pellet, considered 
as the nuclear fraction, was resuspended in sucrose buffer with protease inhibitors and stored at −80 °C until 
use. The cytosolic fraction was obtained by centrifugation of the first 3000 g supernatant at 15000 g for 45 min. 
The resulting supernatant, considered as the cytosolic fraction, was stored at −80 °C until use. The purity of both 
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cellular fractions was tested by western blot using the nuclear protein antibody Lamina. Protein concentration 
was determined in each fraction by the Lowry method.
Western blotting. Immunoblots were done as previously described1. Briefly, proteins were loaded on 
a 12 or 14% polyacrylamide gel for electrophoresis (SDS-PAGE; Bio-Rad, Alcobendas, Spain), and then 
transferred to a nitrocellulose membrane (Hybond-C Extra; Amersham, Barcelona, Spain). After block-
ing, membranes were incubated overnight at 4 °C with the following primary antibodies: (i) rabbit pol-
yclonal antibodies against: XBP1 (ab37151) at 1 μg/mL; VCP-97 (ab11433) at 1/2000 dilution and lamin 
B at 1/1000 dilution from Abcam, Cambridge, UK. Grp78 (#SPA-826) at 1/2000 dilution from Stressgen. 
EDEM2 (E1782) at 1 μg/mL from Sigma-Aldrich, Madrid, Spain. Phospho-S6K (sc-11759) at 1/1000 dilu-
tion and ATF6α (sc-22799) at 1⁄1500 dilution from Santa Cruz Biotechnology, USA. LC3B (#2775); Atg7 
(#2631); p62 (#5114); phospho-Akt (#9271); Akt (#9272); phospho-GSK-3β (#9336); phospho-JNK (#9251); 
JNK (#9252); eIF2α (#9722); ATF4 (#11815); Derlin1 (#8897); mTOR (#2972); phospho-mTOR (#2971) at 
1/1000 dilution from Cell Signaling, Danvers, MA, USA. TFEB (NB100–93447) at 1/1000 dilution from 
Novus, Madrid, Spain. (ii) Mouse or rabbit monoclonal antibodies against IRE1α (#3294); OS9 (#12497); 
Phospho-eIF2α (#3597) at 1⁄1000 dilution from Cell Signaling. GSK-3β (#05-412) at 1⁄1000 dilution from 
Millipore. β-catenin (ab32572) and phospho-IRE1α (ab124945) at 1⁄1000 dilution from Abcam, Cambridge, 
UK. Cathepsin D (AF1C7) at 1⁄2000 dilution from AbFrontier Seoul, Korea. β-actin (A 5316) at 1⁄1000 dilu-
tion from Sigma-Aldrich, Madrid, Spain. Then, membranes were incubated with the appropriate secondary 
antibodies horseradish peroxidase-conjugated from Dako, Denmark at a dilution of 1/10000 and developed 
using the ECL-plus detection method (Amersham, Barcelona, Spain) and the ImageQuant LAS 4000 MINI 
GOLD (GE Healthcare Life Sciences, Barcelona, Spain). For quantification, the optical density of individual 
bands was analyzed using PCBAS 2.08 software (Raytest Inc, Berlin, Germany), and normalized relative to 
the optical density of β-actin or lamin B.
RNA extraction and reverse transcription. For PCR analysis, total RNA was extracted using the Tripure 
Isolation Reagent (Roche, Mannheim, Germany) according to the instructions of the manufacturer. The recovery 
of RNA was similar in young and aged rats. Reverse transcription was performed using random hexamers prim-
ers exactly as previously described1.
Real-time PCR. PCR was performed in an ABI Prism 7000 sequence detector (Applied Biosystems, Madrid, 
Spain) using cDNA diluted in sterile water as template. The xbp1, chop, Atf6, grp78, derlin1, derlin2, vcp/p97, 
edem1, edem2, os9 and the housekeeper genes were amplified using specific Taqman probes supplied by Applied 
Biosystems, Madrid, Spain. The spliced Xbp1 mRNA was amplified using the following pair of primers (from 5′ to 
3′): sXbp1UP: GCTTGTGATTGAGAACCAGG and sXbp1LO: GGCCTGCACCTGCTGCGGACTC7. Threshold 
cycle (Ct) values were calculated using the software supplied by Applied Biosystems, Madrid, Spain.
Cell culture. Microglial N13 cells were cultured in RPMI 1640 medium (Sigma-Aldrich, Madrid, Spain), 
supplemented with 10% heat-inactivated fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin 
(Euroclone, Milano, Italy). Cells were stimulated with 0.5 μg/ml of LPS (L3024 S), from Sigma-Aldrich, Madrid, 
Spain, for 5 hours in the presence or the absence of 20 μM of the GSK-3β inhibitor VII (361548) from Calbiochem, 
UK, or 0.5 μg/ml of LPS for 4 hours followed by 1 μM of bafilomycin A1 (CAS 88899-55-2) for 5 more hours. 
Samples were collected using loading sample buffer and processed for Western blot experiments.
Statistical analysis. Data were expressed as mean ± SD. For comparison between several groups, we used 
a multifactor ANOVA, followed by Bonferroni post hoc multiple comparisons tests (Statgraphics plus 3.1) 
(Warrenton, VA, USA). The significance was set at 95% of confidence. Significant differences are referenced as 
P < 0.05: *respect to saline-injected animals or, #respect to young animals. The comparison between saline and 
LT injected aged rats was done by two-tailed t test.
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